18 Stocks Hit 52-Week Lows On Wednesday
Even as the broader market holds steady, several large and growing companies are hitting their weakest prices of the year.
International Business Machines (IBM), a company with a market value of about $193.1 billion, is trading at its weakest price in a year. As of Wednesday, 18 stocks from the Russell 3000 join it on the 52-week-low list, a notable event when the S&P 500 has returned +0.4% over the last month. The central question is what to make of businesses hitting new lows while their fundamentals may be telling a different story.
The full list of names follows below.
The Full List, Largest First
- Dillard’s Stock Climbs 15% On A 9-Day Winning Streak
- Coupang Stock: 9 Straight Red Days, Down 18%
- How Will Verizon Communications Stock React To Its Upcoming Earnings?
- Where The Buying Ran Strongest: 16 S&P 500 Stocks At 52-Week Highs
- The 52-Week-Low List: 6 S&P 500 Names On Wednesday
- 21 Small Cap Stocks Just Made New 52-Week Highs
Here are all 18 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| IBM | $193.1 Bil | -2.2% | -2.6% | -18.4% | -25.9% |
| MCD | $187.3 Bil | -0.1% | -0.5% | -2.4% | -8.7% |
| ISRG | $120.9 Bil | -2.7% | -12.4% | -15.5% | -34.0% |
| SNPS | $72.3 Bil | -2.9% | -11.2% | -18.7% | -36.2% |
| ALNY | $35.5 Bil | -1.6% | -4.4% | -6.8% | -16.7% |
| CPRT | $25.4 Bil | 0.0% | -0.4% | -7.8% | -41.0% |
| WYNN | $9.7 Bil | -0.3% | -2.8% | -8.9% | -10.5% |
| CHDN | $5.7 Bil | -1.4% | -3.0% | -4.9% | -22.0% |
| PEGA | $4.4 Bil | -16.0% | -16.9% | -11.4% | -49.2% |
| LOPE | $3.7 Bil | -1.2% | -3.6% | -3.8% | -19.6% |
| KLRA | $2.1 Bil | -3.4% | -7.8% | -22.2% | n/a |
| MH | $1.7 Bil | -2.4% | -4.9% | -0.8% | n/a |
| PRCT | $1.0 Bil | -4.4% | -7.6% | -16.0% | -69.0% |
| AGNT | $0.7 Bil | -3.4% | -6.1% | -5.3% | -56.1% |
| GTN-A | $0.6 Bil | -9.9% | -10.3% | -12.0% | -38.6% |
| SPRY | $0.6 Bil | -4.7% | -19.7% | -39.3% | -66.1% |
| UWMC | $0.5 Bil | -3.2% | -9.4% | -10.2% | -53.4% |
| MSIF | $0.5 Bil | -1.0% | -3.1% | -1.7% | -27.4% |
Growth is still visible on the low list.
A new low does not always mean the underlying business has stopped expanding. Intuitive Surgical (ISRG), for instance, saw its revenue grow 21.4% over the last twelve months despite its stock hitting a yearly low. Alnylam Pharmaceuticals (ALNY) shows an even starker contrast, with revenue growth of 82.6% over the same period. Even the giant on the list, IBM, posted revenue growth of 9.7% and maintains a free cash flow yield of 6.3%. These are not businesses in retreat, even if their stock prices are.
A low price is a signal, not a verdict.
A 52-week-low list is a powerful filter for attention. It can surface companies facing genuine operational damage, where the market is correctly pricing in new risk. It can also highlight businesses that have simply fallen out of favor, creating a potential discount. The disciplined approach is to treat the list as the beginning of the work, not the end. The price is a fact, but the health of the business is a judgment that requires a closer look.
A 52-week-low list tells you where the pain is; it does not tell you which of these declines are worth buying. That second question is what our Buy the Dip screen answers, every day: beaten-down names where the fundamentals still hold up.
Weakness Is Information. It Is Not An Instruction
A 52-week low tells you what the market thinks today. It does not tell you what to do, and acting on price alone is how value traps get bought. The missing ingredient is always the same: is the business still sound?
Asking that question across thousands of stocks, every day, is exactly how the Trefis High Quality (HQ) Portfolio is built: roughly 30 names that pass the quality screens, held with rules instead of nerve. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Let the low list sharpen your watchlist, and let the portfolio carry the risk.